{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:07:27Z","timestamp":1792174047907,"version":"4.4.0"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008725","name":"Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Recent studies have indicated the involvement of chemokine-C-motif ligand 1 (XCL1) in nociceptive transmission; however, the participation of its two receptors, canonical chemokine-C-motif receptor 1 (XCR1) and integrin alpha-9 (ITGA9), recently recognized as a second receptor, has not been clarified to date. The aim was to explore by which of these receptors XCL1 reveals its pronociceptive properties and how the XCL1-XCR1 and XCL1-ITGA9 axes blockade\/neutralization influence on pain-related behavior and opioid analgesia in the model of neuropathic pain. In our studies we used Albino Swiss mice which were exposed to the unilateral sciatic nerve chronic constriction injury (CCI) as a neuropathic pain model. Animals received single intrathecal (<jats:italic>i.t.<\/jats:italic>) injection of XCL1, XCL1 neutralizing antibodies, antagonist of XCR1 (vMIP-II) and neutralizing antibodies of ITGA9 (YA4), using lumbar puncture technique. Additionally we performed <jats:italic>i.t.<\/jats:italic> co-administration of abovementioned neutralizing antibodies and antagonists with single dose of morphine\/buprenorphine. To assess pain-related behavior the von Frey and cold plate tests were used. To measure mRNA and protein level the RT-qPCR and Western Blot\/Elisa\/immunofluorescence techniques were performed, respectively. Statistical analysis was conducted using ANOVA with a Bonferroni correction. Presented studies have shown time-dependent upregulation of the mRNA and\/or protein expression of XCL1 in the spinal cord after nerve injury as measured on day 1, 4, 7, 14, and 35. Our immunofluorescence study showed that XCL1 is released by astroglial cells located in the spinal cord, despite the neural localization of its receptors. Our results also provided the first evidence that the blockade\/neutralization of both receptors, XCR1 and ITGA9, reversed hypersensitivity after intrathecal XCL1 administration in naive mice; however, neutralization of ITGA9 was more effective. In addition, the results proved that the XCL1 neutralizing antibody and, similarly, the blockade of XCR1 and neutralization of ITGA9 diminished thermal and mechanical hypersensitivity in nerve injury-exposed mice after 7 days. Additionally, neutralization of XCL1 improves morphine analgesia. Moreover, blockade of XCR1 positively influences buprenorphine effectiveness, and neutralization of ITGA9 enhances not only buprenorphine but also morphine analgesia. Therefore, blockade of the XCL1-ITGA9 interaction may serve as an innovative strategy for the polypharmacotherapy of neuropathic pain in combination with opioids.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1058204","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T11:41:27Z","timestamp":1671709287000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["New insights into the analgesic properties of the XCL1\/XCR1 and XCL1\/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies"],"prefix":"10.3389","volume":"13","author":[{"given":"Agata","family":"Ciechanowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Rojewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Piotrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Barut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Ciapa\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Kreiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Mika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: A systematic review of epidemiological studies","volume":"155","author":"Van Hecke","year":"2014","journal-title":"Pain"},{"key":"B2","article-title":"Pharmacology of opioid and nonopioid analgesics in chronic pain states","volume":"299","author":"Martin","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1852","article-title":"Chemokines: integrators of pain and inflammation","volume":"4","author":"White","year":"2005","journal-title":"Nat Rev Drug Discovery"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2013.01.072","article-title":"Importance of glial activation in neuropathic pain","volume":"716","author":"Mika","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00208","article-title":"Microglial activation in traumatic brain injury","volume":"9","author":"Donat","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-019-0218-1","article-title":"Astrocytes in chronic pain and itch","volume":"20","author":"Ji","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000001219","article-title":"Microglial inhibition influences XCL1\/XCR1 expression and causes analgesic effects in a mouse model of diabetic neuropathy","volume":"125","author":"Zychowska","year":"2016","journal-title":"Anesthesiology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.54","article-title":"Minocycline selectively inhibits M1 polarization of microglia","volume":"4","author":"Kobayashi","year":"2013","journal-title":"Cell Death Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.22038\/ijbms.2017.24248.6053","article-title":"Minocycline through attenuation of oxidative stress and inflammatory response reduces the neuropathic pain in a rat model of chronic constriction injury","volume":"21","author":"Abbaszadeh","year":"2018","journal-title":"Iran J Basic Med Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/J.BBI.2008.07.005","article-title":"Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice","volume":"23","author":"Mika","year":"2009","journal-title":"Brain Behav Immun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2014.08.001","article-title":"Minocycline prevents dynorphin-induced neurotoxicity during neuropathic pain in rats","volume":"86","author":"Rojewska","year":"2014","journal-title":"Neuropharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jneuroim.2014.09.020","article-title":"Involvement of pro- and antinociceptive factors in minocycline analgesia in rat neuropathic pain model","volume":"277","author":"Rojewska","year":"2014","journal-title":"J Neuroimmunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.3735","article-title":"Minocycline attenuates pain by inhibiting spinal microglia activation in diabetic rats","volume":"12","author":"Sun","year":"2015","journal-title":"Mol Med Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2005.04451.x","article-title":"Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia","volume":"22","author":"Hua","year":"2005","journal-title":"Eur J Neurosci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00248","article-title":"Intra-CA1 administration of minocycline alters the expression of inflammation-related genes in hippocampus of CCI rats","volume":"12","author":"He","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2018.01.006","article-title":"The importance of chemokines in neuropathic pain development and opioid analgesic potency","volume":"70","author":"Kwiatkowski","year":"2018","journal-title":"Pharmacol Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pain.2013.06.022","article-title":"Glia and pain: Is chronic pain a gliopathy","volume":"154","author":"Ji","year":"2013","journal-title":"Pain"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2017.09.021","article-title":"Spinal CCL1\/CCR8 signaling interplay as a potential therapeutic target \u2013 evidence from a mouse diabetic neuropathy model","volume":"52","author":"Zychowska","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.03.007","article-title":"Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia","volume":"119","author":"Kwiatkowski","year":"2019","journal-title":"Cytokine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00494","article-title":"Involvement of macrophage inflammatory protein-1 family members in the development of diabetic neuropathy and their contribution to effectiveness of morphine","volume":"9","author":"Rojewska","year":"2018","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13172","article-title":"The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain","volume":"159","author":"Pawlik","year":"2020","journal-title":"Immunology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-017-9729-6","article-title":"The RS504393 influences the level of nociceptive factors and enhances opioid analgesic potency in neuropathic rats","volume":"12","author":"Kwiatkowski","year":"2017","journal-title":"J Neuroimmune Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.781310","article-title":"Blockade of CC chemokine receptor type 3 diminishes pain and enhances opioid analgesic potency in a model of neuropathic pain","volume":"12","author":"Pawlik","year":"2021","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173166","article-title":"CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain","volume":"880","author":"Bogacka","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106540","article-title":"Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses","volume":"84","author":"Kwiatkowski","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011074","article-title":"Comparison of the effects of chemokine receptors CXCR2 and CXCR3 pharmacological modulation in neuropathic pain model\u2013In vivo and in vitro study","volume":"22","author":"Piotrowska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-020-00187-y","article-title":"Traumatic brain injury in mice induces changes in the expression of the XCL1\/XCR1 and XCL1\/ITGA9 axes","volume":"72","author":"Ciechanowska","year":"2020","journal-title":"Pharmacol Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2011.10.003","article-title":"XCL1 and XCR1 in the immune system","volume":"14","author":"Lei","year":"2012","journal-title":"Microbes Infect"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.dci.2019.04.008","article-title":"Genetic diversity of chemokine XCL1 and its receptor XCR1 in murine rodents","volume":"98","author":"Xu","year":"2019","journal-title":"Dev Comp Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4049\/jimmunol.1601329","article-title":"A novel \u03b19 integrin ligand, XCL1\/Lymphotactin, is involved in the development of murine models of autoimmune diseases","volume":"199","author":"Matsumoto","year":"2017","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1311022111","article-title":"Integrin \u03b19 on lymphatic endothelial cells regulates lymphocyte egress","volume":"111","author":"Ito","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.01.013","article-title":"Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain","volume":"560","author":"Mika","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: A new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2002373","article-title":"A method to separate nuclear, cytosolic, and membrane-associated signaling molecules in cultured cells","volume":"4","author":"Liu","year":"2011","journal-title":"Sci Signal"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2015.11.001","article-title":"Sequential fractionation and isolation of subcellular proteins from tissue or cultured cells","volume":"2","author":"Baghirova","year":"2015","journal-title":"MethodsX"},{"key":"B37","unstructured":"CentreTEM\n            CardiologyM\n          Subcellular fractionation protocol. Abcam.6\u20137"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2015.12.013","article-title":"Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine","volume":"71","author":"Pilat","year":"2016","journal-title":"Mol Cell Neurosci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.05.058","article-title":"IL-1 receptor antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model","volume":"764","author":"Pilat","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01241","article-title":"CCR4 antagonist (C021) administration diminishes hypersensitivity and enhances the analgesic potency of morphine and buprenorphine in a mouse model of neuropathic pain","volume":"11","author":"Bogacka","year":"2020","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.615327","article-title":"Bidirectional action of cenicriviroc, a CCR2\/CCR5 antagonist, results in alleviation of pain-related behaviors and potentiation of opioid analgesia in rats with peripheral neuropathy","volume":"11","author":"Kwiatkowski","year":"2020","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02198","article-title":"Pharmacological blockade of spinal CXCL3\/CXCR2 signaling by NVP CXCR2 20, a selective CXCR2 antagonist, reduces neuropathic pain following peripheral nerve injury","volume":"10","author":"Piotrowska","year":"2019","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.07.032","article-title":"Pharmacological blockade of CXCR3 by (\u00b1)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - evidence from in vivo and in vitro studies","volume":"1864","author":"Piotrowska","year":"2018","journal-title":"BBA- Mol Basis Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2018.10.002","article-title":"Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model","volume":"71","author":"Rojewska","year":"2019","journal-title":"Pharmacol Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01891-5","article-title":"Microglia induce the transformation of A1\/A2 reactive astrocytes via the CXCR7\/PI3K\/Akt pathway in chronic post-surgical pain","volume":"17","author":"Li","year":"2020","journal-title":"J Neuroinflamm"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108335","article-title":"JNK\/c-jun-driven NLRP3 inflammasome activation in microglia contributed to retinal ganglion cells degeneration induced by indirect traumatic optic neuropathy","volume":"202","author":"Chu","year":"2021","journal-title":"Exp Eye Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2009.09.030","article-title":"Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain","volume":"623","author":"Mika","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.08.031","article-title":"Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats","volume":"75","author":"Makuch","year":"2013","journal-title":"Neuropharmacology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0003-06.2006","article-title":"Activated microglia contribute to the maintenance of chronic pain after spinal cord injury","volume":"26","author":"Hains","year":"2006","journal-title":"J Neurosci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.4363","article-title":"Neutrophils and b cells express XCR1 receptor and chemotactically respond to lymphotactin","volume":"281","author":"Huang","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2018.03.030","article-title":"A novel role for lymphotactin (XCL1) signaling in the nervous system: XCL1 acts via its receptor XCR1 to increase trigeminal neuronal excitability","volume":"379","author":"Bird","year":"2018","journal-title":"Neuroscience"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2005.09.023","article-title":"Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain","volume":"137","author":"Cai","year":"2006","journal-title":"Neuroscience"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.000232","article-title":"Integrin \u03b19\u03b21 is a receptor for nerve growth factor and other neurotrophins","volume":"121","author":"Staniszewska","year":"2008","journal-title":"J Cell Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4602570","article-title":"Integrin \u03b19 suppresses hepatocellular carcinoma metastasis by rho GTPase signaling","volume":"2018","author":"Zhang","year":"2018","journal-title":"J Immunol Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638400","article-title":"Integrin-\u03b19\u03b21 as a novel therapeutic target for refractory diseases: Recent progress and insights","volume":"12","author":"Xu","year":"2021","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: Bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111493","article-title":"Crucial role of SLP-76 and ADAP for neutrophil recruitment in mouse kidney ischemia-reperfusion injury","volume":"209","author":"Block","year":"2012","journal-title":"J Exp Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900725","article-title":"Alpha9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis","volume":"182","author":"Kanayama","year":"2009","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-48360-5","article-title":"The systemic exercise-released chemokine lymphotactin\/XCL1 modulates in vitro adult hippocampal precursor cell proliferation and neuronal differentiation","volume":"9","author":"Leiter","year":"2019","journal-title":"Sci Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0759-09.2009","article-title":"Alpha9 integrin promotes neurite outgrowth on tenascin-c and enhances sensory axon regeneration","volume":"29","author":"Andrews","year":"2009","journal-title":"J Neurosci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2017.00048","article-title":"Blockade of P2X4 receptors inhibits neuropathic pain-related behavior by preventing MMP-9 activation and, consequently, pronociceptive interleukin release in a rat model","volume":"8","author":"Jurga","year":"2017","journal-title":"Front Pharmacol"},{"key":"B62","article-title":"Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness","volume":"60","author":"Mika","year":"2008","journal-title":"Pharmacol Rep"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-013-0223-1","article-title":"Activation of CXCL10\/CXCR3 signaling attenuates morphine analgesia: Involvement of gi protein","volume":"53","author":"Ye","year":"2014","journal-title":"J Mol Neurosci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.12659\/msm.897702","article-title":"Upregulation of (C-X-C motif) ligand 13 (CXCL13) attenuates morphine analgesia in rats with cancer-induced bone pain","volume":"22","author":"Wang","year":"2016","journal-title":"Med Sci Monit"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13919","article-title":"Involvement of chemokine CXCL11 in the development of morphine tolerance in rats with cancer-induced bone pain","volume":"141","author":"Guo","year":"2017","journal-title":"J Neurochem"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj070484","article-title":"Viewing chemokines as a third major system of communication in the brain","volume":"7","author":"Adler","year":"2006","journal-title":"AAPS J"},{"key":"B67","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.drugalcdep.2006.09.010","article-title":"Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats","volume":"88","author":"Chen","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.102327699","article-title":"Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain","volume":"99","author":"Szabo","year":"2002","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B69","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.pnpbp.2015.07.005","article-title":"Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats","volume":"64","author":"Kwiatkowski","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2006.10.033","article-title":"Integrins regulate opioid receptor signaling in trigeminal ganglion neurons","volume":"144","author":"Berg","year":"2007","journal-title":"Neuroscience"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1058204\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T11:41:32Z","timestamp":1671709292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1058204\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":70,"alternative-id":["10.3389\/fimmu.2022.1058204"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1058204","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"article-number":"1058204"}}